Mélanie A. Hamon

Mélanie A. Hamon


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MDMaziar Divangahi
Maziar Divangahi
PAPeter Aaby
Peter Aaby
SKShabaana Abdul Khader
Shabaana Abdul Khader
LBLuis B. Barreiro
Luis B. Barreiro
SBSiroon Bekkering
Siroon Bekkering
MNMihai G. Netea
Mihai G. Netea

1 June 2006 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
MHMélanie A. Hamon
Mélanie A. Hamon
HBHelene BIERNE
Helene BIERNE
PCPascale Cossart
Pascale Cossart

1 December 2001 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
MHMélanie A. Hamon
Mélanie A. Hamon
BLBeth A. Lazazzera
Beth A. Lazazzera

1 December 2012 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Open access
PDF file
HBHelene BIERNE
Helene BIERNE
MHMélanie A. Hamon
Mélanie A. Hamon
PCPascale Cossart
Pascale Cossart
Epigenetic mechanisms regulate expression of the genome to generate various cell types during development or orchestrate cellular responses to external stimuli. Recent studies highlight that bacteria can affect the chromatin structure and transcriptional program of host cells by influencing diverse epigenetic factors (i.e., histone modifications, DNA methylation, chromatin-associated complexes, noncoding RNAs, and RNA splicing factors). In this article, we first review the molecular bases of the epigenetic language and then describe the current state of research regarding how bacteria can alter epigenetic marks and machineries. Bacterial-induced epigenetic deregulations may affect host cell function either to promote host defense or to allow pathogen persistence. Thus, pathogenic bacteria can be considered as potential epimutagens able to reshape the epigenome. Their effects might generate specific, long-lasting imprints on host cells, leading to a memory of infection that influences immunity and might be at the origin of unexplained diseases.

1 August 2012 in Trends in Microbiology
Verified
Journal Article
Closed access
MHMélanie A. Hamon
Mélanie A. Hamon
DRDavid Ribet
David Ribet
FSFabrizia Stavru
Fabrizia Stavru
PCPascale Cossart
Pascale Cossart

1 July 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SMSerge Mostowy
Serge Mostowy
VSVanessa Sancho-Shimizu
Vanessa Sancho-Shimizu
MHMélanie A. Hamon
Mélanie A. Hamon
RSRoxane Simeone
Roxane Simeone
RBRoland Brosch
Roland Brosch
PCPascale Cossart
Pascale Cossart
Autophagy is an important mechanism of innate immune defense. We have recently shown that autophagy components are recruited with septins, a new and increasingly characterized cytoskeleton component, to intracytosolic Shigella that have started to polymerize actin. On the other hand, intracytosolic Listeria avoids autophagy recognition by expressing ActA, a bacterial effector required for actin polymerization. Here, we exploit Shigella and Listeria as intracytosolic tools to characterize different pathways of selective autophagy. We show that the ubiquitin-binding adaptor proteins p62 and NDP52 target Shigella to an autophagy pathway dependent upon septin and actin. In contrast, p62 or NDP52 targets the Listeria ActA mutant to an autophagy pathway independent of septin or actin. TNF-α, a host cytokine produced upon bacterial infection, stimulates p62-mediated autophagic activity and restricts the survival of Shigella and the Listeria ActA mutant. These data provide a new molecular framework to understand the emerging complexity of autophagy and its ability to achieve specific clearance of intracytosolic bacteria.